Ergoteles LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 142 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$410,000
+98.1%
137,160
+75.3%
0.02%
+100.0%
Q4 2021$207,000
+80.0%
78,265
+196.5%
0.01%
+166.7%
Q2 2021$115,000
+105.4%
26,400
+12.8%
0.00%
-57.1%
Q3 2020$56,00023,4000.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders